Lineage Cell Therapeutics, Inc. (LCTX)
1.205
+0.02
(+1.26%)
USD |
NYAM |
Jun 08, 15:40
Lineage Cell Therapeutics Market Cap : 300.40M for June 8, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Curis, Inc. | 18.79M |
| Halozyme Therapeutics, Inc. | 8.407B |
| Agenus, Inc. | 120.38M |
| Amgen, Inc. | 186.40B |
| BioCryst Pharmaceuticals, Inc. | 2.117B |
Market Cap Related Metrics
| PS Ratio | 19.60 |
| PEG Ratio | -0.0161 |
| Price to Book Value | 5.576 |
| Price | 1.205 |
| Earnings Yield | -23.84% |
| PEGY Ratio | -0.0161 |